NurExone Biologic Inc. (NRXBF)
OTCMKTS
· Delayed Price · Currency is USD
0.5100
-0.0090 (-1.73%)
Jul 3, 2025, 4:00 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of $41.28 million as of July 3, 2025. Its market cap has increased by 61.41% in one year.
Market Cap
41.28M
Enterprise Value
40.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 25.82M to 41.28M, an increase of 59.85%. That is a compound annual growth rate of 16.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 41.28M | 35.14% |
| Dec 31, 2024 | 30.55M | 183.25% |
| Dec 28, 2023 | 10.78M | -11.85% |
| Dec 22, 2022 | 12.24M | -52.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 639.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 557.29M |
| American Oncology Network | 418.01M |
| Northwest Biotherapeutics | 366.72M |